FDA Clearance for Two New Automated Assays
Immunodiagnostic Systems Holdings plc, a leading producer of diagnostic testing kits for the clinical and research markets, announces that clearance has been received from the US Food and Drug Administration (FDA) for the Company’s IGFBP-3 and CTX-I controls, enabling the related automated assays to be sold in the USA.